Stockreport

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

 (RADX) 
PDF Ethics approval received in Australia for the initiation of RAD’s Phase 1 therapeutic trial of 177Lu-RAD202 in Breast and Gastric CancersThe Phase 1 First-In-Human study [Read more]